Assessing the impact of community-based interventions on hypertension and diabetes management in three Minnesota communities: Findings from the prospective evaluation of US HealthRise programs

PLoS One. 2023 Feb 27;18(2):e0279230. doi: 10.1371/journal.pone.0279230. eCollection 2023.

Abstract

Background: Community-based health interventions are increasingly viewed as models of care that can bridge healthcare gaps experienced by underserved communities in the United States (US). With this study, we sought to assess the impact of such interventions, as implemented through the US HealthRise program, on hypertension and diabetes among underserved communities in Hennepin, Ramsey, and Rice Counties, Minnesota.

Methods and findings: HealthRise patient data from June 2016 to October 2018 were assessed relative to comparison patients in a difference-in-difference analysis, quantifying program impact on reducing systolic blood pressure (SBP) and hemoglobin A1c, as well as meeting clinical targets (< 140 mmHg for hypertension, < 8% Al1c for diabetes), beyond routine care. For hypertension, HealthRise participation was associated with SBP reductions in Rice (6.9 mmHg [95% confidence interval: 0.9-12.9]) and higher clinical target achievement in Hennepin (27.3 percentage-points [9.8-44.9]) and Rice (17.1 percentage-points [0.9 to 33.3]). For diabetes, HealthRise was associated with A1c decreases in Ramsey (1.3 [0.4-2.2]). Qualitative data showed the value of home visits alongside clinic-based services; however, challenges remained, including community health worker retention and program sustainability.

Conclusions: HealthRise participation had positive effects on improving hypertension and diabetes outcomes at some sites. While community-based health programs can help bridge healthcare gaps, they alone cannot fully address structural inequalities experienced by many underserved communities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Community Health Services
  • Community Health Workers
  • Diabetes Mellitus* / therapy
  • Glycated Hemoglobin
  • Humans
  • Hypertension* / therapy
  • Hypotension*
  • Minnesota / epidemiology

Substances

  • Glycated Hemoglobin

Grants and funding

Funding of the HealthRise project came from the Medtronic Foundation. The funders were informed of study design, data collection and analysis, decision to publish, and the preparation of manuscript, and had the opportunity to provide feedback. Final decisions for each component – study design, data collection and analysis, decision to publish, and the preparation of the manuscript – were made by the evaluation team overseen at the Institute for Health Metrics and Evaluation (IHME). The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.